From Discovery to Market Entry: CISCAREX Announces a Dietary Supplement for Vitamin A5, the First Newly Identified Vitamin for 80 Years

Vitamin A₅ dietary supplement, MIN A5®, launches on the EU market

BERLIN--(BUSINESS WIRE)--CISCAREX, the Berlin-based start-up founded by the scientists behind the vitamin A₅ discovery, announced today the commercial launch of MIN A5®: a first-of-its-kind vitamin A₅ dietary supplement. Provided as a capsule containing a natural plant extract, MIN A5® is now available to the EU market. MIN A5® will be the first product launch for CISCAREX, whose aim is to commercialize derivatives of the newly identified vitamin A₅ in the food and cosmetic markets as well as for pharmaceutical applications.

MIN A5® is the result of years of research and development led by CISCAREX CEO and co-founder Dr. Dr. Ralph Rühl, along with co-founders Dr. Wojciech Krezel and Prof. Dr. Angel R. de Lera. “Having conducted the discovery and research into vitamin A₅, we’re delighted to now be able to bring a convenient, unique, first-in-class vitamin A₅ supplement to customers,” said Dr. Dr. Rühl. Alongside the scientific team, Friedrich Wasserfall and Dr. Sven Klussmann support the team with a wealth of expertise in logistics, finances and sales of dietary supplements, and experience navigating start-up companies to success.

MIN A5® will initially be launched on CISCAREX’s web shop and in German pharmacies. With additional financial investments and/or strategic partners, CISCAREX intends to expand its direct distribution channels to a wider range of global markets. CISCAREX has exclusive access to the global patent rights protecting vitamin A₅, as well as major trademarks for this new vitamin. With no competitors, CISCAREX presents a promising opportunity for investors and strategic partners. Following the launch of the capsule form of MIN A5®, CISCAREX intends to develop a wider portfolio of products, including healthy vitamin A₅-fortified gummy bears, soft- and hard-drinks, and chewing gums. The different products will target distinct population groups, including vegans, the elderly, women, children/adolescents, and athletes. In addition to developing its own product portfolio, CISCAREX is expecting to enter into partnerships in order to use vitamin A₅ as an ingredient for the fortification of generic food products and animal feed.

What is vitamin A₅?

First identified as recently as 2021, vitamin A₅ marked the first discovery of a new vitamin for 80 years. Vitamin A₅ occurs naturally in fruits and vegetables — particularly in leafy greens and root vegetables. A general nutrient-rich diet and especially these leafy vegetables are key elements in maintaining good mental, cognitive, and physical health. Despite this, up to 75-95% of us in the Western population are failing to meet the recommended dietary intake (RDI) of fruits and vegetables¹, resulting in potential vitamin deficiencies. While existing supplements are available to treat other vitamin deficiencies, until now there have been no solutions available for targeted supplementation of vitamin A₅.

Based on a Consortium Study, the RDI for vitamin A₅ corresponds with a daily consumption of ca. 30 g spinach, 50 g of carrots, or 1800 g of peaches¹. Results from an EU project (data on file) demonstrate that people on a Western-style diet consume less than 50% of the RDI from natural dietary sources.

Designed to address the modern challenges of maintaining a balanced diet, MIN A5® is a plant-extract derived supplement specifically formulated to provide sufficient vitamin A₅ to achieve the recommended daily consumption.

MIN A5® is now available for purchase at www.MINA5.com, as well as in select pharmacies in Germany.

About CISCAREX

Founded in 2019, CISCAREX is a start-up company based in downtown Berlin, managed by entrepreneurs, experts in food and supplement sales, and scientists. CISCAREX is dedicated to developing and marketing products derived from the newly identified vitamin A₅, translating scientific research into health and well-being benefits for customers.

Disclaimer: Dietary supplements are not a substitute for a balanced and varied diet. The stated recommended consumption amount must not be exceeded. Keep out of the reach of children.

----------

¹ Bohn T, Hellman-Regen J, de Lera AR, Böhm V, Rühl R. Human nutritional relevance and suggested nutritional guidelines for vitamin A5/X and provitamin A5/X. Nutr Metab. 2023;20(1):34 and references within.

For investment enquiries, please contact: ralphruehl@ciscarex.com